Pulse Biosciences GAAP EPS of -$0.26 beats by $0.05, revenue of $0.26M beats by $0.01M
Source: SeekingAlpha
2026-02-19 16:47:16 ET
More on Pulse Biosciences
- Pulse Biosciences, Inc. (PLSE) Presents at 31st Annual AF Symposium 2026 - Slideshow
- Pulse Biosciences, Inc. (PLSE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Seeking Alpha’s Quant Rating on Pulse Biosciences
- Historical earnings data for Pulse Biosciences
- Financial information for Pulse Biosciences
Read the full article on Seeking Alpha
For further details see:
Pulse Biosciences GAAP EPS of -$0.26 beats by $0.05, revenue of $0.26M beats by $0.01M
Pulse Biosciences Inc
NASDAQ: PLSE
PLSE Trading
-0.39% G/L:
$17.98 Last:
39,269 Volume:
$18.16 Open:
PLSE Latest News
March 09, 2026 07:00:00 am
Pulse Biosciences Announces Clinical Data From nPulse(TM) Vybrance(TM) System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation
March 05, 2026 07:00:00 am
Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
March 04, 2026 07:00:00 am
Pulse Biosciences' nPulse(TM) Vybrance(TM) System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting
February 20, 2026 07:00:00 am
Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
PLSE Stock Data
$1,654,206,579
17,212,965
N/A
28
N/A
Medical Equipment & Supplies
Healthcare
US
Miami
